Among methylation marker genes extracted to define these subgroups, TFPI2 was the most frequently hypermethylated gene in MM, low expression of which significantly correlated with poorer prognosis of MM, and knockdown of TFPI2 led to increased cellular growth and invasion of MM. The gene discussed is TFPI2; the disease is Miyoshi myopathy.